A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Sudan Ebolavirus Vaccine in Healthy Adults

NCT06803342 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Ebola Sudan Virus Disease

Interventions

BIOLOGICAL: cAd3-Sudan Vaccine
BIOLOGICAL: Placebo

Sponsor

Albert B. Sabin Vaccine Institute

Collaborators

[object Object]